(Q44044333)

29 November 2017

title

Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys (English)

1 reference

29 November 2017

Kuo-Hsing Ma

1

1 reference

29 November 2017

Wen-Sheng Huang

2

1 reference

29 November 2017

Chien-Hsing Chen

3

1 reference

29 November 2017

Shin-Zong Lin

4

1 reference

29 November 2017

Shiaw-Pyng Wey

5

1 reference

29 November 2017

Gann Ting

6

1 reference

29 November 2017

Shwun-De Wang

7

1 reference

29 November 2017

Hwan-Wun Liu

8

1 reference

29 November 2017

Jiang-Chuan Liu

9

1 reference

29 November 2017

publication date

1 July 2002

1 reference

Nuclear Medicine and Biology

29 November 2017

published in

1 reference

29 November 2017

volume

29

1 reference

29 November 2017

issue

5

1 reference

29 November 2017

page(s)

561-567

1 reference

[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Imaging of dopamine transporters in humans with technetium-99m TRODAT-1

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

[99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

A reappraisal of the relative merits of SPET and PET in the quantitation of neuroreceptors: the advantage of a longer half-life!

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Imaging of D2 dopamine receptors of patients with Parkinson's disease using single photon emission computed tomography and iodobenzamide I 123.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) denervation in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Multiple system atrophy: a review of 203 pathologically proven cases

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2802%2900303-7

7 January 2021

10.1016/S0969-8051(02)00303-7

Identifiers

DOI

1 reference

29 November 2017

1 reference